Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Fliban 100mg

Generic: Flibanserinby Centurion Laboratories Pvt. Ltd.

Buy Fliban 100mg (Flibanserin) online | SafeRxPills

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Cabanex 0.5mg (Cabergoline) online | SafeRxPills

Cabanex 0.5mg

$81.60View
Buy Caberlin 0.25mg (Cabergoline) online | SafeRxPills

Caberlin 0.25mg

$21.00View
Caberlin 0.5mg tablet pack

Caberlin 0.5mg

$42.00View
Buy Cabgolin 0.25mg (Cabergoline) online | SafeRxPills

Cabgolin 0.25mg

$21.00View

About Fliban 100mg

Fliban 100mg is a flibanserin 100 mg tablet for low sexual desire in women, the condition doctors call hypoactive sexual desire disorder (HSDD). Flibanserin is the medicine sold in the US and Canada as Addyi. It is not a hormone and it is not a "female Viagra": it is taken every night at bedtime, not before sex, and it acts on serotonin and dopamine receptors in the brain, although the US label says its mechanism in HSDD "is not known". The pack we sell is an Indian pack sold for export (we found no Indian pharmacy listing for it); the carton in our product photo holds one strip of 4 tablets and does not name the maker. We sell packs of 12, 20 and 40 tablets, from $4.70 a tablet in the 40 pack.

Four points first. The benefit in trials was modest: about half to one extra satisfying sexual event a month compared with placebo. Alcohol close to a dose can cause severe low blood pressure and fainting, so there is a strict alcohol rule. The label says to stop after 8 weeks if there is no improvement, and none of our packs covers 8 weeks on its own. And in the US, the brand Addyi is FDA approved and its maker's website quotes $149 a month for cash buyers, which is less per tablet than our 12 and 20 packs and about the same as our 40 pack, so US readers should start there. This page sets out the doses, warnings and prices from the current US Addyi prescribing information (December 2025) and the Canadian Addyi product monograph (November 2025), listed at the end.

Fliban 100mg at a glance

Active ingredientFlibanserin 100 mg per tablet (a non-hormonal medicine that acts on serotonin and dopamine receptors)
Brand and makerFliban, Indian export pack. The carton in our product photo does not name the maker. Our listing names Centurion Laboratories; one Indian exporter listing (GNH India) names Healing Pharma India. We have not confirmed which is right
Licensed use (US)Addyi: women less than 65 years of age with acquired, generalized HSDD that causes marked distress or interpersonal difficulty and is not due to another medical or psychiatric condition, relationship problems, or a medicine or drug. Since December 2025 this includes postmenopausal women under 65. Not for men
Regulatory statusFlibanserin is licensed as Addyi in the US (FDA, 2015) and Canada (Health Canada, 2018), prescription only in both. This Indian Fliban pack is not registered with the FDA or Health Canada. We found no flibanserin medicine licensed in the UK, authorised by the EMA, or registered in Australia
Usual dose from the labelOne 100 mg tablet once a day at bedtime; there is no other strength (US label 2.1)
Half-lifeAbout 11 hours (US label 12.3); steady blood levels after 3 days of dosing
Review pointStop after 8 weeks if there is no improvement (US label 2.3; Canadian monograph 4.2)
Packs12, 20 and 40 tablets (strips of 4)
Price per tablet$6.50 (12 pack) down to $4.70 (40 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per tablet

Prices below are as of October 2026; the pack selector shows the current price.

PackPricePer tabletShippingPer tablet with shippingNights it lasts
12 tablets$78$6.50$25$8.5812
20 tablets$100$5.00$25$6.2520
40 tablets$188$4.70Free$4.7040

The 40 pack is over the $149 free shipping line; the 12 and 20 packs carry $25 shipping. The larger packs are cheaper per tablet before shipping too.

How long a pack lasts, and the 8 week review. The label dose is one tablet every night, so a pack lasts as many nights as it has tablets. The US label says to discontinue Addyi "after 8 weeks if the patient does not report an improvement in her HSDD symptoms" (2.3). Eight weeks is 56 nights. None of our packs covers that on its own: the 12 pack lasts under 2 weeks, the 20 pack under 3 weeks and the 40 pack under 6 weeks. If you and your doctor decide on a full 8 week trial, a 40 pack plus a 20 pack gives 60 tablets for $288 with free shipping ($4.80 a tablet). That is our arithmetic, not a label figure. Do not buy months of supply before you know whether it helps you and whether you can live with the side effects; the US label says most of the common side effects began within the first 14 days.

Compared with Addyi

Fliban 100mg (ours)Addyi 100 mg (US)
MakerNot confirmed (see above)Sprout Pharmaceuticals
FDA approvedNo (Indian export pack)Yes, since 18 August 2015
TabletPink, triangular in our product photoPink, oval, marked "f100"
Cost per tablet$4.70 to $6.50 before shippingAbout $4.97 at the $149 a month cash price on addyi.com, if a month is 30 tablets (our arithmetic)
Cost for about 8 weeks$288 for 60 tablets (40 + 20 packs, free shipping)About $298 for two months at $149

There is no US generic flibanserin, and the US Medicaid NADAC file (the average price US pharmacies pay to buy a medicine) has no row for Addyi or flibanserin in its 2026 data, so we cannot quote a pharmacy acquisition cost. The maker's website, checked on 21 October 2026, says Addyi is "only $149/month through PHILRx" for cash buyers and that "Patients with insurance coverage pay as little as $20 per month", and it links to a telehealth visit. A US price guide (Drugs.com, undated) puts the cash price at around $1,961 for 30 tablets, depending on the pharmacy, with prices listed from $349 for 30 tablets. If you are in the US, the licensed brand through the maker's pharmacy route costs about the same as our largest pack and less than our smaller packs once shipping is added, comes with the FDA-approved Medication Guide, and does not depend on an unconfirmed maker. We would choose that route first.

We have not seen any study comparing the Indian Fliban tablet with Addyi, so we cannot say it releases the medicine in the same way. A different tablet shape is expected from a different maker and tells you nothing either way.

One strength only

Flibanserin is made in one strength, 100 mg, in both the US and Canadian labels. There is no lower starting dose and no higher dose for people who see little effect. The Canadian monograph says to "Counsel patients to not exceed the recommended dose", and the US label says the risk of low blood pressure and fainting rises "if higher than the recommended dose is taken" (5.4). Never take two tablets in one night, and never take a tablet during the day to make up for a missed one.

What the evidence says

The US approval in premenopausal women rests on three 24 week placebo-controlled trials of 2,375 women whose average age was 36 (US label 14.1). Women recorded "satisfying sexual events", which counted intercourse, oral sex, masturbation or genital stimulation by a partner that they rated as satisfying.

  • Satisfying sexual events. At the start, women had about 2.5 to 3 a month. By week 24 this rose by 1.6 to 2.5 a month on flibanserin and by 0.8 to 1.5 a month on placebo. The median difference from placebo was 1.0 a month in Study 1 and 0.5 a month in Studies 2 and 3 (Table 6).
  • Desire. In Studies 1 and 2, the daily diary measure of desire, a co-primary endpoint, showed no statistically significant difference from placebo. On the desire questions of the Female Sexual Function Index (scored 1.2 to 6), flibanserin scored 0.3 to 0.4 points more than placebo in all three trials.
  • How many women felt "much improved". In a supportive analysis, 29% to 39% on flibanserin and 21% to 31% on placebo rated themselves much or very much improved on satisfying events, a difference of 8 to 9 percentage points.
  • Dropouts. 69% of women on flibanserin and 78% on placebo completed the trials.

The December 2025 approval for postmenopausal women under 65 rests on one 24 week trial in naturally postmenopausal women (Study 6). From a starting point of 2.0 a month, satisfying events rose 0.9 a month on flibanserin and 0.6 on placebo, an adjusted difference of 0.4 a month (95% confidence interval -0.0 to 0.8 as printed in the label, so the lower limit is about zero). The desire score difference was 0.3 points (US label 14.2, Table 7). Women with significant other illnesses were excluded from that trial.

An independent meta-analysis of eight trials and 5,914 women (Jaspers 2016, JAMA Internal Medicine) found that flibanserin "on average, resulted in one-half additional SSE per month", with about four times the risk of dizziness and of sleepiness, and graded the quality of the evidence as very low. Our reading: some women do notice a real change, many do not, and the 8 week stop rule exists for that reason.

How to take Fliban 100mg

  1. Take one tablet once a day at bedtime, every night, whether or not you plan to have sex (US label 2.1). The label says it is dosed at bedtime "because administration during waking hours increases the risks of hypotension, syncope, accidental injury, and central nervous system (CNS) depression".
  2. Follow the alcohol rule in the next section every evening.
  3. If you miss a bedtime dose, skip it and take the next dose at bedtime the next day. The Medication Guide says: "Do not take ADDYI the next morning or double your next dose."
  4. Do not drive, use machinery or do anything that needs full alertness until at least 6 hours after a dose and until you know how it affects you (US label 5.3).
  5. Do not drink grapefruit juice while you take it (Medication Guide).
  6. Review it with your doctor at 8 weeks. Both labels say to stop if there is no improvement by then (the Canadian monograph: no improvement in sexual desire and/or no reduction in the distress that goes with it).

The labels give no rule on food. Food increased absorption of a 50 mg dose by up to about 1.6 times after a high fat meal (US label 12.3).

The alcohol rule

The US label carries a boxed warning, its strongest kind, on low blood pressure and fainting. It says: "The use of ADDYI and alcohol together close in time increases the risk of severe hypotension and syncope." Its instruction:

  • "Counsel patients to wait at least two hours after consuming one or two standard alcoholic drinks before taking ADDYI at bedtime or to skip their ADDYI dose if they have consumed three or more standard alcoholic drinks that evening."
  • "After taking ADDYI at bedtime, advise patients to not use alcohol until the following day." (5.1)

The label defines one standard drink as 14 grams of alcohol: a 12 ounce regular beer (5%), 5 ounces of wine (12%) or 1.5 ounces of spirits (40%). In metric that is about 355 mL of beer, 150 mL of wine or 44 mL of spirits (our conversion). By our arithmetic, a UK pint (568 mL) of 5% beer is about 1.6 standard drinks and a 250 mL glass of 12% wine about 1.7, so two of either already counts as three or more.

Why the rule is strict: in a label study of 25 healthy people (23 of them men), 4 of 23 who took flibanserin with alcohol equal to about two drinks, at the same time, needed treatment for low blood pressure or fainting, with falls in systolic pressure of 28 to 54 mmHg. The dedicated alcohol studies were done in premenopausal women and men; the US label says no dedicated alcohol studies were done in postmenopausal women, and the Canadian monograph says postmenopausal women should be told of the risk.

The rule used to be stricter. When Addyi was approved in 2015, the label listed use with alcohol as a contraindication, and prescribers and pharmacies had to be specially certified under an FDA safety programme (a REMS). In 2019 the FDA replaced that contraindication with the two hour rule (it ordered the labelling change in April 2019 and approved the new labelling in October 2019), and in October 2019 it also removed the certification requirement after new alcohol studies showed, in the FDA's words, that "the risk with alcohol is narrower than understood at the time of approval". In January 2025 the FDA said a REMS was "no longer required" for Addyi; the alcohol warning stays in the boxed warning and the Medication Guide.

Medicines and supplements that interact

  • Moderate or strong CYP3A4 inhibitors: contraindicated (US label 4, 7). The US label names ketoconazole, itraconazole, posaconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, boceprevir, telaprevir, telithromycin and conivaptan (strong), and amprenavir, atazanavir, ciprofloxacin, diltiazem, erythromycin, fluconazole, fosamprenavir, verapamil and grapefruit juice (moderate). With fluconazole, flibanserin levels rose 7-fold and 3 of 15 healthy volunteers had low blood pressure or fainted; one became unresponsive with a blood pressure of 64/41 and needed hospital care (6.1, 12.3).
  • Timing around these medicines (US label 2.4): start flibanserin 2 weeks after the last dose of a moderate or strong CYP3A4 inhibitor; start the inhibitor 2 days after the last dose of flibanserin. If you are prescribed one of these for an infection, tell the prescriber you take flibanserin.
  • Weak CYP3A4 inhibitors, such as oral contraceptives, cimetidine, fluoxetine, ginkgo and ranitidine: taking several together may increase the risk of side effects; discuss them with your doctor (US label 7). In the trials, women on hormonal contraception had more dizziness (13.4% vs 9.9%), sleepiness and tiredness on flibanserin than women who were not.
  • Strong CYP2C19 inhibitors: the US label gives proton pump inhibitors, SSRIs, benzodiazepines and antifungals as examples and says to discuss them with your doctor, because flibanserin levels may rise.
  • Other medicines that cause drowsiness, such as diphenhydramine, opioids, sleeping tablets and benzodiazepines, add to the sleepiness (US label 7).
  • CYP3A4 inducers (carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine, St John's wort): "not recommended" in the US label, because they cut flibanserin levels sharply (rifampin by 95%).
  • Digoxin and other P-glycoprotein substrates: flibanserin doubled digoxin exposure. The US label says to increase monitoring of narrow-range drugs such as digoxin; the Canadian monograph lists use with P-gp substrates (digoxin) as a contraindication.
  • Herbal supplements: the Medication Guide says not to take St John's wort, ginkgo or resveratrol, or over-the-counter cimetidine, until you have talked to your doctor.

Tell your doctor and pharmacist about every medicine, supplement and herbal product you take before you start, and before you start anything new.

Side effects

The US label tables pool the trials of 100 mg at bedtime in women under 65.

EffectPremenopausal: flibanserinPremenopausal: placeboPostmenopausal: flibanserinPostmenopausal: placebo
Dizziness11.4%2.2%7.9%3.3%
Sleepiness (somnolence)11.2%2.9%7.7%1.8%
Nausea10.4%3.9%6.6%3.9%
Fatigue9.2%5.5%3.0%3.9%
Insomnia4.9%2.8%5.7%3.4%
Dry mouth2.4%1.0%2.4%1.3%
Anxiety1.8%1.0%2.6%1.6%
Constipation1.6%0.4%2.5%1.8%
Stopped because of side effects13%6%9%5%

Selected rows from US label Tables 1 and 2 (1,543 premenopausal women on flibanserin and 1,556 on placebo; 801 postmenopausal women on flibanserin and 797 on placebo). The table counts adverse reactions reported by at least 2% of women on flibanserin and more often than on placebo; it leaves out urinary tract infection and sinusitis rows. Most of these reactions began within the first 14 days.

  • Sleepiness, sedation or fatigue together: 21% vs 8% in premenopausal women and 10% vs 6% in postmenopausal women (US label 5.3).
  • Low blood pressure and fainting without alcohol or interacting medicines: hypotension 0.2% vs under 0.1%, fainting 0.4% vs 0.2% in premenopausal women (5.4).
  • Appendicitis: 6 of 3,973 premenopausal women on flibanserin (0.2%) and none of 1,905 on placebo (6.1).
  • After approval (no reliable frequency, US 6.2): allergic reactions including anaphylaxis and swelling of the face, lips and mouth; vomiting; weakness; feeling abnormal or "feeling drunk"; headache; near-fainting; unsteady walking; blurred vision; "brain fog".
  • Animal finding: female mice given flibanserin for 2 years at exposures 3 and 10 times those at the recommended human dose had more malignant breast tumours; male mice and rats did not. The label says "The clinical significance of these findings is unknown" (5.7).

When to get urgent help

  • Feeling faint or light-headed after a dose. The Medication Guide says: "If you take ADDYI and you feel lightheaded or dizzy, lie down right away." Get emergency medical help, or ask someone to get it for you, if the symptoms do not go away or you feel you could faint. If you do faint, get medical attention promptly and tell your doctor (US label 5.4).
  • Signs of an allergic reaction: the US label lists anaphylaxis, swelling of the face, lips and mouth, itching and hives, and says to stop flibanserin immediately and start appropriate treatment (5.6). If you have trouble breathing or swallowing, call emergency services (our advice).
  • Taking more than one tablet, or a tablet together with alcohol or an interacting medicine. The Medication Guide says to call your doctor if you take too much; the label says an overdose may make any side effect more frequent or more severe and that there is no specific antidote (10). If you are very drowsy, confused or faint, call emergency services (our advice).

Tell the emergency staff that you took flibanserin (Addyi), how much and when, and what you drank and what other medicines you took.

Who should not take Fliban 100mg

Never take it if:

  • you take a moderate or strong CYP3A4 inhibitor (see the list above) (US label 4; Canadian monograph 2)
  • you have any degree of liver impairment. In mild liver impairment flibanserin exposure rose 4.5-fold and its half-life was 26 hours instead of 10 (US label 4, 8.6, 12.3)
  • you have had an allergic reaction to flibanserin or any ingredient of the tablet (US label 4; Canadian monograph 2)

The Canadian monograph also lists as contraindications: pregnancy or breastfeeding; a resting systolic blood pressure below 110 mmHg or diastolic below 60 mmHg in women who use alcohol, "as this was not studied"; and taking P-glycoprotein substrates such as digoxin.

Not indicated, not recommended, or only after a talk with your doctor:

  • Men: "ADDYI is not indicated in men" (US label 1).
  • To improve sexual performance: "ADDYI is not indicated to enhance sexual performance" (US label 1).
  • Age: the US indication covers women less than 65 years of age, and the label says Addyi "is not indicated for the treatment of HSDD in geriatric patients" (8.5). The Canadian indication covers premenopausal and naturally postmenopausal women aged 60 or under. Children: the US label says it is not indicated in pediatric patients (8.4); the Canadian monograph says safety and efficacy are not established under 18 (1.1).
  • Low desire with another cause: the label indication excludes low desire due to another medical or psychiatric condition, relationship problems, or a medicine or drug. Depression, some antidepressants, hormonal changes, pain during sex and relationship strain can all lower desire, and they need their own assessment first.
  • Breastfeeding: the US label says Addyi "is not recommended in breastfeeding women" because of possible sedation in the baby (8.2); the Canadian monograph contraindicates it.
  • Pregnancy: there are no studies in pregnant women; animal studies at high doses showed harm to the fetus alongside harm to the mother (US 8.1). The Canadian monograph contraindicates it. Tell your doctor if you are pregnant or planning a pregnancy.
  • Low blood pressure or conditions that cause it: the US label says to weigh the benefit against the risk of low blood pressure and fainting (5.4).
  • Alcohol or drug misuse, or a history of depression or other mental health problems: the Medication Guide asks you to tell your doctor about these before you start.
  • CYP2C19 poor metabolisers (about 2% to 5% of Caucasian and African people and 2% to 15% of Asian people): flibanserin levels are higher, and the US label says to increase monitoring for side effects such as low blood pressure (8.7).

Prescription and legal status

In the US, Addyi is a prescription medicine ("Rx only"), first approved on 18 August 2015 and extended in December 2025 to women under 65 regardless of menopausal status. There is no US generic. The FDA says personal importation of unapproved medicines is illegal in most circumstances. In Canada, Addyi (DIN 02473550) is a prescription medicine, marketed since November 2018 according to the Health Canada Drug Product Database. In the UK, we found no flibanserin medicine on the electronic medicines compendium, which is not the full MHRA register, and none in the EMA's list of medicines authorised in the EU, so flibanserin is an unlicensed medicine there as far as we can tell. In Australia we found no flibanserin product in our searches of the TGA and healthdirect websites, though the TGA's register search would not load for us. In India, a CDSCO expert committee recommended permission to manufacture and market flibanserin for one company (Hetero) in June 2019, on conditions including bioequivalence study results and a Phase IV study protocol, and said it should be sold only on the prescription of a urologist, gynaecologist or psychiatrist; we found no Indian pharmacy listing for Fliban and no final approval record. Check the rules where you live.

Buying genuine Fliban

The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and it advises UK buyers to "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers this Indian Fliban pack. When your order arrives, read the strip and carton: they should say flibanserin tablets 100 mg, with a batch number, expiry date and a "Mfd. by" line naming the maker. Tell us if the maker shown differs from the ones named on this page. Another company in Bangladesh (Square Pharmaceuticals) also sells a flibanserin tablet called Fliban; it is a different product. These checks cannot prove that tablets are genuine, because counterfeiters copy packaging. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.

Delivery

We ship Fliban 100mg to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days. Shipping costs a flat $25 on orders under $149 and is free from $149. Store the tablets at room temperature; the US label stores Addyi at 25 C, with short periods from 15 to 30 C allowed. See our shipping page and refund policy.

Sources

  • ADDYI (flibanserin) tablets, US prescribing information and Medication Guide, Sprout Pharmaceuticals, revised 12/2025 (DailyMed setid 3819daf3-e935-2c53-c527-e1d57922f394, version 15, effective 22 December 2025): boxed warning and sections 1, 2.1 to 2.4, 3, 4, 5.1 to 5.7, 6.1, 6.2, 7, 8.1, 8.2, 8.4 to 8.7, 10, 12.1 to 12.5, 13.1, 14.1 to 14.3, 16, 17. DailyMed
  • US Food and Drug Administration. Addyi NDA 022526 approval history (original approval 18 August 2015) and letters: S-008 and S-009 (9 October 2019, REMS modification removing the elements to assure safe use), S-012 (21 January 2025, "a REMS is no longer required"), S-013 (December 2025, indication extended to women less than 65 years of age independent of reproductive status). S-009, S-012, S-013
  • US Food and Drug Administration. Addyi REMS, initial approval 08/2015 (prescriber and pharmacy certification). FDA
  • ADDYI product monograph, Health Canada, Sprout Pharmaceuticals, date of initial authorization 27 February 2018, revised 25 November 2025: sections 1, 1.1, 1.2, 2, 3, 4.1 to 4.5. Health Canada Drug Product Database, DIN 02473550, status marketed, schedule prescription, checked 21 October 2026. Product monograph
  • Jaspers L, et al. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA Intern Med. 2016. PMID 26927498. PubMed
  • Addyi website (Sprout Pharmaceuticals): cash price "$149/month through PHILRx" and insured price "as little as $20 per month", checked 21 October 2026. addyi.com
  • Drugs.com Addyi price guide, cash price around $1,961 for 30 tablets depending on the pharmacy, listed from $349 for 30 tablets (undated), checked 21 October 2026. Drugs.com
  • Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026: no rows for Addyi (NDC 58604-0214-30) or flibanserin, searched 21 October 2026. data.medicaid.gov
  • European Medicines Agency medicines data file (no flibanserin entry) and electronic medicines compendium search ("No search results for flibanserin"), checked 21 October 2026. emc
  • CDSCO. Recommendations of the SEC (Reproductive and Urology), 42nd meeting, 18 June 2019, item 1 (flibanserin tablets, M/s Hetero). CDSCO
  • Indian export listing for Fliban 100 mg (GNH India: Healing Pharma India Pvt Ltd, 4 tablets, ambient storage) and Bangladesh listing for Square Pharmaceuticals' Fliban (MedEx), checked 21 October 2026.
  • MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
  • US Food and Drug Administration. Personal Importation. FDA

This page is for information and is not medical advice. Flibanserin is a prescription medicine where it is licensed. Low sexual desire has many possible causes; see a doctor first, and take flibanserin only if a doctor who knows your other medicines and your drinking habits agrees it is right for you.

Frequently asked questions

What is Fliban 100mg?

Fliban 100mg is an Indian export pack of flibanserin 100 mg tablets, the medicine sold in the US and Canada as Addyi. It is used for low sexual desire in women that causes marked distress (hypoactive sexual desire disorder, HSDD) and is not caused by another condition, a relationship problem or a medicine. It is not a hormone and it is not taken before sex: it is one tablet every night at bedtime. Flibanserin is licensed as Addyi in the US and Canada, but this Indian pack is not registered with the FDA or Health Canada.

Is Fliban the same as Addyi?

It contains the same medicine at the same strength, flibanserin 100 mg, but it is not the same product. Addyi is a Sprout Pharmaceuticals product, is FDA approved and is a pink oval tablet marked f100; the tablets in our product photo are pink and triangular. We have not confirmed the maker of our Fliban pack (our listing names Centurion Laboratories; one Indian exporter names Healing Pharma India), and we have seen no study comparing it with Addyi.

How much does Fliban 100mg cost per tablet?

As of October 2026, $6.50 a tablet in the 12 pack, $5.00 in the 20 pack and $4.70 in the 40 pack, before shipping. Shipping is $25 under $149 and free from $149, so the 12 and 20 packs work out at $8.58 and $6.25 a tablet with shipping. The pack selector shows the current price. In the US, the maker's website quotes Addyi at $149 a month for cash buyers, about $4.97 a tablet by our arithmetic, so US readers should compare that first.

How do I take Fliban 100mg?

Take one tablet once a day at bedtime, every night, whether or not you plan to have sex. The US label says bedtime dosing is because taking it while awake raises the risk of low blood pressure, fainting, injury and sleepiness. If you miss a dose, skip it and take the next one at bedtime the next day; do not take it the next morning or double the next dose. Do not drive or use machinery until at least 6 hours after a dose and until you know how it affects you, and do not drink grapefruit juice.

Can I drink alcohol while taking Fliban?

Only within the label's rule. The US label says to wait at least two hours after one or two standard drinks before taking the bedtime dose, to skip that night's dose after three or more drinks, and not to drink alcohol after the bedtime dose until the following day. A US standard drink is 14 g of alcohol: 12 ounces of 5% beer, 5 ounces of 12% wine or 1.5 ounces of spirits. By our arithmetic a UK pint of 5% beer is about 1.6 standard drinks, so two pints already counts as three or more.

How long does flibanserin take to work, and when should I stop?

The labels give no onset time; the trials measured results after 24 weeks. Both the US and Canadian labels say to stop after 8 weeks if there is no improvement. In the main US trials, women on flibanserin had a median of 0.5 to 1 more satisfying sexual event a month than women on placebo, and an independent meta-analysis put the average gain at about half an event a month. Some women notice a clear change, many do not.

Can I take two tablets or a stronger dose?

No. Flibanserin comes in one strength, 100 mg, once a day at bedtime. There is no higher dose for people who see little effect, and the US label says the risk of low blood pressure and fainting rises if more than the recommended dose is taken. The Canadian monograph says patients should be told not to exceed the recommended dose. If one tablet a night has not helped by 8 weeks, the label says to stop, not to take more.

What are the side effects of Fliban 100mg?

In US label trials in premenopausal women, dizziness affected 11.4% on flibanserin against 2.2% on placebo, sleepiness 11.2% against 2.9%, nausea 10.4% against 3.9% and fatigue 9.2% against 5.5%; most began within the first 14 days. 13% stopped because of side effects against 6% on placebo. Low blood pressure and fainting can happen even without alcohol, and the risk rises with alcohol, interacting medicines, daytime dosing or extra tablets. Allergic reactions have been reported.

Who should not take Fliban 100mg?

Never take it with a moderate or strong CYP3A4 inhibitor (for example fluconazole, ketoconazole, itraconazole, clarithromycin, erythromycin, ciprofloxacin, diltiazem, verapamil, some HIV and hepatitis C medicines, or grapefruit juice), with any degree of liver impairment, or if you are allergic to it. It is not for men or to enhance sexual performance. The US indication covers women under 65 (premenopausal or postmenopausal); the Canadian one covers women aged 60 or under. The Canadian label also contraindicates pregnancy, breastfeeding and P-glycoprotein substrates such as digoxin.

Do I need a prescription for flibanserin, and is it legal to import?

Addyi is prescription only in the US and Canada. We found no flibanserin medicine licensed in the UK or registered in Australia, so it is unlicensed there. The FDA says personal importation of unapproved medicines is illegal in most circumstances, and the MHRA advises UK buyers to use only UK-registered pharmacies. In India, a CDSCO expert committee said flibanserin should be sold only on the prescription of a urologist, gynaecologist or psychiatrist. Check the rules where you live, and see a doctor before taking it.

How long does delivery take?

Standard delivery to the US, UK, Australia and Canada takes 7 to 14 business days, in plain packaging with tracking. Shipping is a flat $25 on orders under $149 and free from $149. Because the label review point is 8 weeks (56 nights) and our largest pack is 40 tablets, plan with your doctor how much you need before you order, rather than buying several months at once.

Guide to Female Infertility & Ovulation InductionHow clomiphene triggers ovulation in PCOS and anovulatory women, success rates, dosing protocol, how to time sex around Clomid, and what to do if it does not work.

Related articles

Customer Reviews

No reviews yet. Bought Fliban 100mg? Tell other buyers how it went.